Home/Filings/4/0001104659-25-025193
4//SEC Filing

Sawicki Mark W 4

Accession 0001104659-25-025193

CIK 0001124524other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 7:06 PM ET

Size

9.0 KB

Accession

0001104659-25-025193

Insider Transaction Report

Form 4
Period: 2025-03-14
Sawicki Mark W
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2025-03-14+9,00087,528 total
  • Sale

    Common Stock

    2025-03-17$6.29/sh2,092$13,16285,436 total
  • Award

    Stock Option (right to buy)

    2025-03-14+24,00024,000 total
    Exercise: $7.05Exp: 2032-03-14Common Stock (24,000 underlying)
Footnotes (3)
  • [F1]Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.
  • [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
  • [F3]1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.

Issuer

Cryoport, Inc.

CIK 0001124524

Entity typeother

Related Parties

1
  • filerCIK 0001848218

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:06 PM ET
Size
9.0 KB